In a regulatory filing, Chemed president and CEO Kevin McNamara disclosed the sale of 4,000 common shares of the company on May 16 at a price of $567.54 per share.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHE: